JAN 03, 2017 08:30 PM PST

Dendritic Cell Vaccines Promising For Breast Cancer

WRITTEN BY: Kara Marker

A vaccine for cancer is on the horizon, although it works in a way different to what most people might consider a conventional vaccine. Using a personalized approach, scientists from the Moffitt Cancer Center are on the brink of a new treatment option for breast cancer patients.

Researchers tested the safety and efficacy of the new vaccine technology in a clinical trial with 54 women all diagnosed with early-stage breast cancer. The other quality these women shared was that their breast cancer cells expressed HER2, a protein that is overexpressed in nearly a quarter of all breast cancers and which is unfortunately linked to cases of a particularly aggressive cancer and a poor prognosis.

Expressing HER2 works for cancer cells because immune cells that are designed to fight tumors cannot recognize and target cancer cells as well when they display this protein on their cell surface, as if the immune system didn’t already have enough on its plate in a case of cancer.

This is where the idea came to create a vaccine of sorts, designed for dendritic cells. The vaccine helps the immune system relearn to recognize HER2, and researchers could extract dendritic cells from each breast cancer patient to cater a dendritic cell vaccine specifically to each person.

Vaccines in the clinical trial were reinjected into a lymph node, breast tumor, or both once a week for six weeks. Results showed that the treatment was well received and women experienced only low-grade toxicity, if any. Not many cancer treatments can say the same. Very few side effects occurred, with the most common being fatigue, injection site reactions, and chills.

Remarkably, researchers saw a clear immune response to the vaccine in 80 percent of evaluable patients, and all of the responses were similar despite variation of vaccine administration location.

"These results suggest that vaccines are more effective in [ductal carcinoma in situ (DCIS, an early non-invasive disease)], thereby warranting further evaluation in DCIS or other minimal disease settings, and the local regional sentinel lymph node may serve as a more meaningful immunologic endpoint," explained Brian J. Czerniecki, MD, PhD

The present study was published in the journal Clinical Cancer Research.

Source: Moffitt Cancer Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 18, 2019
Cancer
AUG 18, 2019
A new spray that can stop skin cancer recurrence and metastasis
Cancer recurrence and metastasis are the leading causes of death in cancer patients; this is why researchers at UCLA developed something that could help in stopping recurrence or metastasis i...
AUG 18, 2019
Immunology
AUG 18, 2019
Vaccination Helps Prevent Diabetes
A drop in the number of young children diagnosed with type 1 diabetes could be associated with the introduction of routine rotavirus vaccination....
AUG 18, 2019
Immunology
AUG 18, 2019
High Res Look Into the Brain of MS
Researchers have revealed a subtype of immune cell aiding in the autoimmune disorder Multiple Sclerosis...
AUG 18, 2019
Health & Medicine
AUG 18, 2019
Drug-resistant Candida Auris is Spreading
A drug-resistant fungal yeast, Candida auris, is spreading throughout hospitals worldwide. Deemed “an urgent threat” by the Center for Disease...
AUG 18, 2019
Cardiology
AUG 18, 2019
Opioid Addiction Comes With Increased Risk Of Infection
Public health officials have put decades of work into the battle against infectious diseases. Now, this progress is at risk of being dismantled. A recent s...
AUG 18, 2019
Cancer
AUG 18, 2019
How cancer tricks our immune systems
Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s ...
Loading Comments...